Grantham, Mayo, Van Otterloo & Co (GMO)’s Cactus WHD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.8M Buy
376,109
+51,456
+16% +$2.7M 0.05% 197
2025
Q4
$14.8M Sell
324,653
-140,535
-30% -$5.87M 0.04% 211
2025
Q3
$18.4M Buy
465,188
+4,341
+0.9% +$183K 0.05% 178
2025
Q2
$20.1M Sell
460,847
-279,174
-38% -$11.7M 0.06% 178
2025
Q1
$33.9M Buy
740,021
+291,423
+65% +$16.1M 0.11% 128
2024
Q4
$26.2M Buy
448,598
+17,607
+4% +$1.11M 0.09% 159
2024
Q3
$25.7M Buy
430,991
+43,820
+11% +$2.55M 0.08% 168
2024
Q2
$20.4M Buy
387,171
+280,221
+262% +$14.3M 0.07% 195
2024
Q1
$5.36M Buy
+106,950
New +$4.74M 0.02% 306
2021
Q1
Sell
-71,509
Closed -$1.86M 948
2020
Q4
$1.86M Buy
+71,509
New +$1.62M 0.01% 458
2020
Q2
Sell
-41,200
Closed -$478K 835
2020
Q1
$478K Buy
+41,200
New +$1.03M ﹤0.01% 603

Other funds holding WHD

Grantham, Mayo, Van Otterloo & Co (GMO)'s WHD Position: Q1 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) increased its Cactus (WHD) stake by 16% in Q1 2026, buying an estimated $2.7M and bringing the position to 376,109 shares worth $17.8M. The position accounts for 0.05% of the portfolio, ranked #197.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in WHD in Q1 2020 and has held it in 11 quarters since. The position peaked at $33.9M in Q1 2025. 324 funds tracked by Wall St. Rank hold WHD as of Q1 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 376,109 shares of Cactus worth $17.8M as of Q1 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) bought 51,456 Cactus shares in Q1 2026, an estimated $2.7M.
  • Cactus made up 0.05% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q1 2026, its #197 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Cactus in Q1 2020 and has held it in 11 quarters since.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Cactus position peaked at $33.9M in Q1 2025.
  • 324 funds tracked by Wall St. Rank held Cactus as of Q1 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2026, filed 14 May 2026.